GLP-1 agonist medications such as Ozempic and Wegovy are in high ... patients prescribed a GLP-1 agonist had a 65 percent lower risk of gallbladder cancer and 62 percent lower risk of a central ...

As more people resort to a new generation of drugs to achieve the perfect body, Leah Hardy examines the latest warnings over ...

Fiber, a crucial nutrient for balanced diet, is gaining attention as a potential weight loss supplement and colorectal cancer ...

A European health authority has found that medications containing semaglutide—such as Ozempic, Wegovy, and Rybelsus—can ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

There is no evidence that Ozempic or other GLP-1 drugs increase the risk of pancreatic cancer. In fact, the opposite may be true. Real-world data, covering the experiences of hundreds of thousands ...

Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

Mounjaro, Ozempic and other fat-melting injections ... no medications have been proven to lower the cancer risk associated with obesity. 'Our study begins to fill that gap by evaluating GLP ...